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Background: The total burden of influenza in primary care is difficult to assess. The 
case definition of medically attended “acute respiratory infection” (MAARI) in the 
German physician sentinel is sensitive; however, it requires modelling techniques to 
derive estimates of disease attributable to influenza. We aimed to examine the impact 
of type/subtype and age.
Methods: Data on MAARI and virological results of respiratory samples (virological 
sentinel) were available from 2001/02 until 2014/15. We constructed a generalized 
additive regression model for the periodic baseline and the secular trend. The weekly 
number of influenza- positive samples represented influenza activity. In a second step, 
we distributed the estimated influenza- attributable MAARI (iMAARI) according to the 
distribution of types/subtypes in the virological sentinel.
Results: Season- specific iMAARI ranged from 0.7% to 8.9% of the population. Seasons 
with the strongest impact were dominated by A(H3), and iMAARI attack rate of the 
pandemic 2009 (A(H1)pdm09) was 4.9%. Regularly the two child age groups (0- 4 and 
5- 14 years old) had the highest iMAARI attack rates reaching frequently levels up to 
15%- 20%. Influenza B affected the age group of 5- to 14- year- old children substan-
tially more than any other age group. Sensitivity analyses demonstrated both compa-
rability and stability of the model.
Conclusion: We constructed a model that is well suited to estimate the substantial 
impact of influenza on the primary care sector. A(H3) causes overall the greatest num-
ber of iMAARI, and influenza B has the greatest impact on school- age children. The 
model may incorporate time series of other pathogens as they become available.
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1  | INTRODUCTION
The total burden of influenza in primary care is difficult to assess. Part 
of the challenge is that influenza cases are both frequent and may 
present clinically as a variety of syndromes. While the common notion 
is that influenza presents with fever and systemic symptoms, such as 
headache or myalgia, it is now well known that a large proportion of in-
fluenza disease may present also as a mild form, indistinguishable from 
the illness caused by other respiratory viruses.1 Thus, syndromic (com-
bined with virological) surveillance systems have been put in place in 
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many countries to monitor intensity and spread of influenza. The two 
major syndrome categories that have been used are acute respiratory 
illness (ARI) and influenza- like illness (ILI). Among European coun-
tries, a considerable variation of case definitions has been employed 
for both syndromes.2 ILI case definitions may include the presence of 
fever3 (or another systemic symptom)4 in addition to one or more re-
spiratory symptoms. In contrast, ARI case definitions usually do not 
require an obligatory presence of fever or feverishness.4 As a result, ILI 
case definitions are more specific, but less sensitive compared to ARI, 
and as a corollary surveillance systems using ILI see more pronounced 
illness waves and peaks during influenza epidemics. However, because 
only a portion of all symptomatic influenza cases are captured by ILI 
case definitions,1,5-9 ILI surveillance systems are less well suited to de-
scribe and capture the burden of disease of influenza.
In 2013, we published results of a cyclic regression (“sin/cos- 
excess model”) model that estimated the excess burden of MAARI 
during periods of influenza circulation compared to a baseline (using 
a combination of sine and cosine curves) that was established for 
all weeks leaving out periods of influenza circulation.10 We demon-
strated that the season- specific attack rate (cumulative incidence) of 
influenza- attributable MAARI (iMAARI) is lower in older age groups. 
We demonstrated also that the order among the child age groups 
(aged 0- 4 and 5- 14 years, respectively) varies; that is, in some years 
children aged 0- 4 years had the highest attack rate, in others children 
aged 5- 14 years. Because we worked with ARI data, this model en-
abled us to estimate the total number and attack rate of iMAARI in 
primary care. In strong seasons, such as in 2004/05 or 2008/09, up to 
9% of the general population (i.e. seven of 82 million inhabitants) were 
seeking health care due to an influenza infection.
In the sin/cos- excess model, the periods of influenza circulation 
were determined using virological data. These data also include type 
and subtype information for influenza, and therefore, we intended to 
develop a model that allows to derive the number and the attack rate 
of MAARI attributable to influenza type and subtype stratified by age 
group. We also wanted to overcome a limitation of the sin/cos- excess 
model that produced occasionally negative excesses during some weeks 
of a period of influenza circulation. These occurred, for example, at the 
end of such a period, because influenza was still confirmed in the labora-
tory; however, the impact on the primary care sector had waned already. 
Moreover, the sin/cos- excess model could not easily be generalized to 
estimate the weekly number of MAARI attributable to other relevant 
pathogens, such as respiratory syncytial virus (RSV), human metapneu-
movirus (hMPV) or rhinovirus, which we have started to systematically 
collect only since 2013/14. The model presented in this study should be 
capable in the future to incorporate these upcoming data, too.
2  | METHODS
2.1 | Data
In Germany, national surveillance for influenza on primary care level is 
organized by the “Working Group for Influenza” (“Arbeitsgemeinschaft 
Influenza” (AGI); influenza.rki.de), which collects data on medically 
attended ARI (MAARI).11 Briefly, sentinel physicians in Germany 
cooperate in the AGI covering approximately 1%- 1.5% of the total 
population of approximately 82 million persons. Physicians report ag-
gregated age group- specific frequencies of patients presenting with 
acute respiratory illness (syndromic surveillance). “Acute respiratory 
illness” is defined as pharyngitis, bronchitis or pneumonia with or with-
out fever. Data are collected in the following age groups: 0- 4, 5- 14, 
15- 34, 35- 59 and 60 years and older. Data are sent to and analysed by 
the AGI (influenza.rki.de) yielding the MAARI attack rate by age group 
and calendar week. Physicians record illness syndromes regardless if 
an individual patient had presented already earlier in the season with 
the same syndrome. Thus, an individual patient may contribute illness 
data more than once in a given season. However, a second occurrence 
of an illness of an individual patient is only recorded again if at least 
2 weeks have passed after the first incident.10 In addition, a subset of 
about 20% of the sentinel physicians collects respiratory samples from 
patients with influenza- like illness (ILI) which are sent to the National 
Reference Center for influenza (NRCI). During the study period, physi-
cians participating in the virological surveillance arm were requested 
to take respiratory samples from patients presenting with influenza- 
like illness. “Influenza- like illness” was defined as acute respiratory ill-
ness with fever and cough or sore throat. Physicians were asked to 
take at least one, but not more than two samples from a given age 
group (0- 4 years, 5- 14, 15- 34, 35- 59 and 60+ years). All samples were 
tested and typed in the NRCI by real- time PCR for presence of influ-
enza A, B and the subtypes A(H1N1) and A(H3N2).10 For the study, 
we used data from the syndromic and virological surveillance arm of 
the AGI comprising the period 2001/02 through 2014/15, for a total 
of 14 seasons, including the pandemic 2009/2010.
2.2 | GAM sample- based Model
We used the age- specific weekly MAARI attack rate mt as dependent var-
iable and developed a generalized additive regression model12 with linear 
link function to analyse this curve. The model was stratified with respect 
to age group; to simplify the notation, we omitted in the formulas the 
subscript for age group. We denoted by it the (age group- specific) num-
ber of respiratory samples with ILI having tested positive for influenza in 
week t. From hereon, we refer to it as the course of laboratory- confirmed 
influenza. We made the following assumptions in each age group:
1. The MAARI attack rate mt can be described as additive com-
position of a periodic baseline, a secular trend and the iMAARI 
attack rate.
2. In each season, the course of the laboratory-confirmed influenza, it, 
mirrors the course of the attack rate of influenza-attributable ILI 
(iMAILI) in the total population.
3. In each season, the age group-specific proportion of iMAILI among 
the iMAARI is approximately constant over the weeks.
We modelled the periodic MAARI baseline using a penalized cyclic 
p- spline f(pt) with at most 52 knots—one for each calendar week; here, pt 
counts the calendar weeks of the year. The secular trend was modelled 
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by a penalized p- spline g(t) with at most 7 knots (1 for every two seasons). 
The third component of the model is it multiplied by a season- specific 
factor st, where st describes the season week t belongs to. The formula of 
the expected weekly MAARI attack rate for each age group (five models) 
then looks as follows:
Hence, we estimated the expected iMAARI attack rate in week t as 
When this model is used prospectively, the inclusion of it with a 
season- specific factor is only useful after the start of a period of influ-
enza circulation, for example as defined in an der Heiden,10 after the 
lower confidence limit of the proportion of samples positive for influ-
enza in the NRCI exceeds 10% in two consecutive weeks. A potential 
season without a period of influenza circulation should be disregarded.
In weak seasons, the estimated coefficient 𝛽st, of a particular age 
group might be a negative number, as the observed MAARI may lie 
beyond the baseline. In this case, the expected iMAARI attack rate in 
this age group will be negative throughout the season. We conclude 
then, that it cannot be quantified and put it to zero.
In a second step, we subdivided the estimated iMAARI attack rate 
according to the distribution of types and subtypes, A(H1), A(H3) or B 
(Figure 1, top), in the respiratory samples. A(H1) before the pandemic 
2009 was named A(H1)prepan, and A(H1) from 2009 onwards, the 
year of the pandemic, was named A(H1)pdm09. To obtain a more sta-
ble estimate of the subtype distribution dt of week t, we used the sub-
type information of all- influenza- positive specimens tested in weeks 
t−1, t and t + 1. We made the following additional assumption:
4. The (age-specific) distribution dt of influenza subtypes describes 
the distribution of samples among iMAILI patients in the total 
population and is a valid proxy for the distribution of samples 
among iMAARI patients.
We combined the uncertainties of the estimated iMAARI and the 






it and the Dirichlet distribution 
d̂t=(nt(H1pdm09),nt(H1prepan),nt(H3),nt(B)). The latter describes 
the uncertainty in the (sub)type distribution; nt is the number of samples 
having tested positive for the respective (sub)type in week t and its two 
neighbouring weeks.
The expected iMAARI attack rate associated with influenza of sub-
type τ is then given by 
Based on the consideration that a high influenza attack rate in one 
season may lead to a relative immunity of at least 1 year (until the 
virus has drifted sufficiently to evade immunity), one could postulate 
that a season with a higher attack rate (overall, or in a particular type/
subtype) may be followed by a lower attack rate and vice versa. We 
therefore attempted to “predict” the magnitude of iMAARI attack rates 
(by type/subtype and overall) based on the magnitude of the preced-
ing season. To do that, we built thirteen pairs with the iMAARI attack 
rate of the season of interest as dependent variable and that of the 
preceding season as explanatory variable (the first season (2001/02) 
had no preceding season and dropped out). We used a Poisson regres-
sion to quantify the associations between the pairs and checked both 
qualitatively and with pseudo- R2 how well these considerations were 
met by the data.
2.3 | Sensitivity analysis
S1: To check the stability of our model, we modified the number 
of seasons included in our model (Equation 1). We estimated the 
iMAARI season attack rate starting with the use of the entire his-
tory of seasons, that is from 2001/02. We then applied the GAM 
sample- based model to data sets that consecutively omitted his-
toric seasons beginning with the most distant ones first until only 
five seasons of data remained. Thus, for the seasons 2010/11 to 
2014/15 ten different estimates were calculated. The resulting 
estimates for the iMAARI attack rate were compared for all age 




(3)E(êt,𝜏 )=E(êt) ⋅ d̂t(𝜏).
F IGURE  1 Raw data (medically attended acute respiratory illness (MAARI) in per cent of the population (hollow dots), data modelled by the 
GAM sample- based model (baseline; green line), secular trend (blue line), MAARI attributed to influenza (iMAARI; red- shaded area). Vertical lines 
represent the change of the year, Germany, 2001/2002–2014/2015
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S2: To gauge the effect of varying degrees of freedom in the sec-
ular trend, we also considered a model with a more flexible secular 
trend that allowed 1 df per included season, that is 14 df instead of 
7. We estimated the iMAARI attack rates in an ongoing season sim-
ulating from retrospective data that additional information becomes 
available as the season is evolving. We used season 2013/14 as exam-
ple and calculated (cumulative) iMAARI attack rates for all age groups 
combined and for the five age groups separately.
S3: To understand better the differences of our previous (sin/
cos- excess) model10 to the GAM sample- based model presented 
in this study, we compared iMAARI attack rates derived from these 
two models with each other. Moreover, we considered an intermedi-
ate model “GAM- excess” model that incorporates characteristics of 
both the sin/cos- excess model and the GAM sample- based model. 
It leaves out periods of influenza circulation for model building (as 
done in the sin/cos- excess model10) but uses penalized p- splines for 
the secular trend and the cyclic component (as in the GAM sample- 
based model).
All estimations including the fitting of generalized additive models 




The GAM sample- based model (described by Equation 1) showed a 
good fit to the data in various aspects (Figure 1). The model had an ad-
justed R2 value of 97.4%, and 98.8% of the deviance in the data could 
be explained by the model. We found a decreasing secular trend that 
stabilized after 2009. The period pattern showed increased MAARI 
activity (without influenza) in autumn and throughout the winter. 
After periods of influenza circulation (red- shaded areas in Figure 1), 
MAARI activity declined and reached the annual lowest points around 
the middle of the year. Troughs can be seen during the weeks around 
the change of the year and smaller troughs during weeks around the 
autumn holidays in Germany. Nevertheless, in several seasons, for ex-
ample during the years 2002, 2003 and 2005, there is MAARI activity 
in the autumn in addition to that captured by the model.
3.2 | Virological data
The frequency and proportional distribution of (sub)types varied con-
siderably from season to season (Figure 2, top panel; Table 1). Until 
2009 (the pandemic season), A(H1)prepan, A(H3) and B cocirculated, 
albeit not in every season to the same degree. After the advent of 
A(H1)pdm09 in 2009, circulation of A(H1)prepan ceased, and A(H3) 
and B paused, but continued to cocirculate together with A(H1)pdm09 
from 2010/11. Seasons where only one type or subtype dominated 
almost exclusively were rare and occurred only in 2003/04 (A(H3)) and 
during the pandemic 2009/10 (A(H1)pdm09). All other seasons expe-
rienced some degree of simultaneous and overlapping circulation of 
two or three types or subtypes. However, only in some seasons, such 
as in 2001/02 and 2005/06 peaks of types or subtypes occurred at 
the same time, and were desynchronized otherwise.
3.3 | Influenza- attributable MAARI
In most seasons, we found a considerable amount of MAARI ex-
plained by circulation of influenza viruses (iMAARI; red- shaded areas 
in Figure 1) with a wide variation among seasons (Figure 2, bottom 
panel; Table 1). The proportion of the population with iMAARI ranged 
from 0.74% in 2003/04 (0.6 million individuals) to 8.9% in season 
2012/13 (7.2 million individuals; Table 1). In the median influenza sea-
son, 3.4% of the population (2.8 million individuals) consulted a physi-
cian due to their influenza infection (interquartile range, 2.3%- 6.0% 
(1.9- 4.9 million individuals)). The pandemic in 2009 led to an iMAARI 
attack rate of 4.9% (4.0 million persons) of the population, but is sur-
passed in magnitude during the time period analysed (2001- 2015) by 
five non- pandemic seasons.
The ratio of the number of confirmed influenza specimens 
(Figure 2, top panel) to the iMAARI attack rate (Figure 2, bottom) dif-
fered among seasons, showing the necessity of a season- dependent 
factor in Equation 1. For example, in season 2002/03 the number of 
influenza- positive samples was substantially higher than in season 
2004/05, whereas the estimated number of iMAARI was higher in 
2004/05 (Figure 2; Table 1 (column 4)).
A somewhat alternating pattern of stronger and weaker seasons 
between 2001/02 and 2008/09 was interrupted by the pandemic 
2009. However, since 2011/12 this pattern seems to have picked 
up again (Figure 2); among the types and subtypes, this pattern can 
be observed only for A(H3) (Figure 3, top panel). In general, seasons 
with the strongest impact (2002/03, 2004/05, 2008/09, 2012/13 
and 2014/15) were dominated by A(H3), except for 2012/13, where 
also A(H1)pdm09 and B cocirculated and led to iMAARI to a similar 
degree as A(H3) (Figure 2, bottom panel; Table 2; Figure 3). Overall, 
there were seven (sub)type–seasons where a type or subtype led 
to at least 3% iMAARI in the population. Five (71%) of these were 
caused by A(H3), two (29%) by A(H1)pdm09, none by A(H1)prepan 
and none by influenza B. On the other hand, dominance of A(H3) did 
not always lead to strong seasons: also some of the weakest seasons 
(2003/04, 2011/12 and 2013/14) were dominated by A(H3). During 
the 14 seasons and among the three types and subtypes, A(H3) led 
to the highest iMAARI attack rate in eight (57%) of the seasons, 
A(H1) in four (29%) and B in two (14%). Except in 2003/04, at least 
two (sub)types led to iMAARI attack of at least 0.2% of the popula-
tion (150 000 individuals; Table 2); in only one season (2013/14), no 
subtype led to an iMAARI attack rate of more than 0.5% (Table 2; 
400 000 individuals); and in only one season (2012/13), all three 
subtypes led to an iMAARI rate of more than 2.5% of the population.
Summed up over all 14 seasons, a total of 48.2 million physician 
visits occurred by patients with influenza. The majority of iMAARI 
(53%) was caused by A(H3) followed by influenza B (23%), A(H1)
pdm09 (19%) and A(H1)prepan (5%; Figure 3, right panel). Both A(H1) 
subtypes together were responsible for roughly a quarter of all iMAARI 
in the total study period.
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Seasonal iMAARI attack rates varied by age (Figure 4). For all three 
types and subtypes and in all seasons, one or both of the two child 
age groups (0- 4, 5- 14) had the highest iMAARI attack rates, with only 
one exception. For influenza B, in 2014/15 the 35- to 59- year- old age 
group had the highest attack rate. Generally, after the two child age 
groups the age- specific iMAARI attack rate decreased with increasing 
F IGURE  2 Top panel: number of influenza confirmations by type and subtype among sentinel respiratory samples, by season. Bottom panel: 
type- and subtype- specific influenza- attributable medically attended acute respiratory illnesses (iMAARI), in % of the population, by season. The 
extra vertical line indicates the beginning of the pandemic A(H1)pdm09. A(H1)prepan=pre- pandemic A(H1)
(A)
(B)
TABLE  1 Frequency distribution of the number of respiratory specimens positive for influenza taken by sentinel physicians, as well as estimated 














2001/02 2935 802 2.1 (1.5- 2.7) 2.5 (1.8- 3.3)
2002/03 4376 2000 5 (4.4- 5.6) 6.1 (5.3- 6.8)
2003/04 2831 583 0.6 (0.2- 1.2) 0.7 (0.2- 1.5)
2004/05 3792 1171 5.5 (4.9- 6.2) 6.7 (5.9- 7.5)
2005/06 1934 632 1.9 (1.3- 2.5) 2.3 (1.6- 3.0)
2006/07 2841 1245 3.3 (2.6- 4.0) 4 (3.2- 4.9)
2007/08 2513 1101 2.2 (1.4- 3.0) 2.7 (1.8- 3.6)
2008/09 3416 1698 4.6 (3.9- 5.4) 5.6 (4.8- 6.6)
2009/10 3526 1179 4 (3.3- 4.8) 4.9 (4.0- 5.9)
2010/11 2950 1419 2.1 (1.4- 2.9) 2.6 (1.8- 3.6)
2011/12 1789 411 0.8 (0.4- 1.5) 1 (0.5- 1.8)
2012/13 3961 1840 7.2 (6.3- 8.0) 8.9 (7.8- 9.9)
2013/14 2290 243 0.6 (0.2- 1.2) 0.8 (0.3- 1.5)
2014/15 3934 1461 7.1 (6.2- 8.0) 8.7 (7.6- 9.9)
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age. In eight (57%) of 14 seasons, at least one of the two child age 
groups had an attack rate of more than 10%. In the pandemic season 
2009/10, the age group 5- 14 was by far the most affected and had an 
iMAARI attack rate that was more than two times higher than either 
the 0- to 4- or the 15- to 34- year- old age group.
Figure 5 (top panel) sums up the age- and season- specific all- 
influenza iMAARI attack rates displaying the median and the inter-
quartile range of all 14 seasons. The median seasonal attack rates were 
approximately 9% in both child age groups and 4% among the 15- to 
34- year- old age group and went down to approximately 0.5% among 
the 60+.
In Table 3, we categorized the age patterns of the season attack 
rates into three classes: (i) “low” meaning that all age-specific attack 
rates in a season were below 1%; (ii) “monotone” means the pattern 
was not low and the age group 0- 4 had the highest attack rate, that 
is generally decreasing to that of age group 60+, that had the small-
est attack rate or was below 0.5%; and (iii) “skewed hat” means the 
season was not low and the age group 5- 14 had the highest attack 
rate, that is generally decreasing to that of age group 60+ that had 
the smallest attack rate or was below 0.5%. The low, monotone and 
skewed- hat patterns are shown as icons in Table 3. The typical pat-
tern was “monotone” for A(H1) and A(H3) and “skewed hat” for B.
In the right panel of Figure 5, the age- specific iMAARI attack rates 
are summed up by (sub)type for those seasons that followed the typ-
ical pattern. The median ratio of the iMAARI attack rates of the age 
group 0- 4 to the age group 5- 14 was 1.28 (IQR: 1.17- 2.02) for influ-
enza A(H1) and 2.43 (IQR: 2.36- 2.73) for influenza A(H3). In contrast, 
for influenza B this ratio was 0.41 (IQR: 0.28- 0.55).
F IGURE  3 Top panel: estimated number of influenza- attributable medically attended acute respiratory infections (iMAARI) by influenza 
type/subtype and season; green=A(H1) (pre- pandemic A(H1) (A(H1)prepan) and A(H1)pdm09 not separated), red=A(H3), blue=B. Bottom panel: 
distribution of all iMAARI accumulated for all seasons from 2001/02 until 2014/15, by type/subtype. Colours denote influenza types and 
subtypes; in contrast to the top panel, A(H1)prepan (orange) and A(H1)pdm09 (green) are coloured separately
(A)
(B)
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TABLE  2 Number of A(H1)- , A(H3)- and B- positive respiratory samples collected by sentinel physicians in each season and estimated attack 
rate of medically attended acute respiratory infections due to influenza types and subtypes (iMAARI)
Season A(H1) A(H3) B



















2001/02 0 417 385 0.0 (0.0- 0.1) 1.2 (0.8- 1.7) 1.3 (0.9- 1.6)
2002/03 1 1720 279 0.0 (0.0- 0.1) 5.3 (4.6- 6.0) 0.8 (0.7- 0.9)
2003/04 0 578 5 0.0 (0.0- 0.1) 0.7 (0.2- 0.5) 0.0 (0.0- 0.1)
2004/05 215 806 150 1.1 (0.9- 1.2) 4.9 (4.2- 5.6) 0.8 (0.7- 0.9)
2005/06 22 102 508 0.1 (0.1- 0.1) 0.5 (0.3- 0.7) 1.7 (1.2- 2.3)
2006/07 124 1110 11 0.3 (0.3- 0.4) 3.7 (2.9- 4.5) 0.0 (0.0- 0.1)
2007/08 572 15 514 1.3 (0.9- 1.8) 0.1 (0.0- 0.1) 1.3 (0.8- 1.8)
2008/09 104 1226 368 0.3 (0.2- 0.3) 4.4 (3.6- 5.2) 1.0 (0.8- 1.1)
2009/10 1174 2 3 4.5 (3.7- 5.4) 0.2 (0.1- 0.3) 0.2 (0.1- 0.3)
2010/11 882 9 528 1.7 (1.1- 2.3) 0.0 (0.0- 0.1) 0.9 (0.6- 1.2)
2011/12 4 9 97 0.0 (0.0- 0.1) 0.8 (0.4- 1.4) 0.2 (0.1- 0.4)
2012/13 618 310 647 3.3 (2.9- 3.7) 2.8 (2.4- 3.2) 2.8 (2.5- 3.1)
2013/14 73 148 22 0.2 (0.1- 0.5) 0.5 (0.2- 0.9) 0.1 (0.0- 0.2)
2014/15 219 910 332 1.3 (1.1- 1.5) 5.3 (4.6- 5.9) 2.2 (1.9- 2.5)
F IGURE  4 Age- and season- specific attack rate of influenza- attributable medically attended acute respiratory illnesses (iMAARI), in % of age 
group
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All- influenza iMAARI attack rates of a season predicted the iMAARI 
attack rate in the following season relatively well; strong seasons were 
followed by weaker ones and vice versa (Figure 6). McFadden´s pseu-
do- R² has a value of 61%, showing that most of the variation can be 
explained by the Poisson model. For A(H3) and B, the model fitted data 
less good, and even worse for A(H1); this corresponds to pseudo- R² of 
36% and 39% for A(H3) and B, respectively, and only 1.9% for A(H1). 
For A(H3), the data points group in two locations, either on a low level 
or on a higher level, representing the up- and down- rhythm of A(H3) 
seasons. In other words, a strong A(H3) season is followed by a weak 
A(H3) season (less than 1% of the population), whereas a weak A(H3) 
season is less narrowly predictive. The two dots on the A(H3) graph in 
the lower left corner represent the first and second season after the 
pandemic season.
3.4 | Sensitivity analysis
S1: Using our GAM sample- based model on different data sets and 
comparing the estimates for the included seasons showed that the 
estimated iMAARI attack rate in a given season depends on the whole 
history of data included (Fig. S1A). Nevertheless, most changes lie in-
side the range given by the 95% confidence intervals. Moreover, the 
differences within seasons are substantially smaller than the differ-
ences between seasons; hence, the ranking of the seasons regarding 
the iMAARI attack rate was quite stable. Considering only seasons 
after the pandemic season 2009/10 leads to systematically higher es-
timates for the iMAARI attack rates. These are due to deviations in 
the two child age groups (Fig. S1B). In contrast, estimates for the age 
groups 15- 34, 35- 59 and 60+ demonstrated remarkable stability inde-
pendently of the history of seasons included in the models.
S2: Using a GAM sample- based model with a more flexible secular 
trend, that is 1 df per one instead of two included seasons, led to less 
stability regarding the estimated iMAARI attack rate in the current sea-
son. We demonstrate the estimates in the course of season 2013/14 
as an example (Fig. S2A). In particular, in calendar week 11/2014 the 
estimate was too high and had to be corrected downwards thereaf-
ter. In addition, iMAARI of the age group 0- 4 was quite instable as 
it seemed to overshoot not only in the latter part of the season but 
also very early on (Fig. S2D). In comparison, the model using the less 
flexible secular trend resulted in more stable estimates (Fig. S2C). This 
confirmed our choice of a relatively inflexible trend with 7 df.
S3: Comparing the estimated iMAARI season attack rates showed 
that the intermediate (GAM- excess) model and the GAM sample- 
based model agreed by and large, whereas the previous (sin/cos- 
excess) model10 led in several seasons to noticeably higher estimates. 
The one exception is the pandemic (Fig. S3A). This relates to the fact 
that the baseline in the sin/cos- excess model showed in most sea-
sons a bimodal course with two peaks of similar height separated by 
the turn of the year (Fig. S3B). The GAM sample- based model, how-
ever, has a lower peak before the turn of the year and a higher peak 
in January/February. As the influenza epidemic almost always starts 
after the turn of the year, the resulting excess of MAARI is therefore 
higher in the sin/cos- excess model. Again the exception of this rule is 
the 2009 pandemic which occurred in October/November. The sin/
cos- excess model calculates a lower number of iMAARI for the 2009 
pandemic compared to the GAM sample- based model.
F IGURE  5 Top panel: attack rates of influenza- attributable 
medically attended acute respiratory infections (iMAARI), median 
of 14 seasons (2001/02- 2014/15), by age (shown are mid- points of 
five age groups). Bottom panel: age- specific median and interquartile 
range of iMAARI attack rates across all seasons with typical pattern 
stratified by type/subtype. Points for the medians were connected by 
lines to guide the eye
(A)
(B)
TABLE  3 Number of seasons with a particular pattern of the 
attack rates over the age groups
Pattern of age group- specific attack rates
Monotone Skewed hat Low
INV subtype
A(H1) 6 2 6
A(H3) 7 4 3
B 1 9 4
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In the season 2005/06, the baseline of the sin/cos- excess model10 
(Fig. S3B) during the period of influenza circulation is very similar to 
that of the intermediate (GAM- excess) and GAM sample- based model 
resulting in similar iMAARI estimates (Fig. S3A). However, in the sea-
son 2006/07 the lower pre- influenza MAARI rates “pull” the baseline 
during the period of influenza circulation somewhat down (circle in 
2006/07 in Fig. S3B) resulting in higher iMAARI estimates compared 
to those generated by the intermediate (GAM- excess) and GAM 
sample- based model (Fig. S3A).
4  | DISCUSSION
We have developed a model that uses virological type and subtype as 
well as age specific data from sentinel physician surveillance to “ex-
plain” MAARI attributable to influenza using a GAM regression model. 
Output from this model includes estimates of consultation burden on 
primary care level stratified by influenza type, subtype and age.
This type of model is warranted because we have collected ARI 
consultations which have a high background rate and are a more 
non- specific indicator for influenza than ILI. On the other hand, be-
cause of the sensitive case definition (ARI), it has the advantage that 
burden estimations (with the aim to calculate disability- adjusted life- 
years (DALY)) on primary care level need no further multiplier but can 
be calculated directly.
Compared to data from other countries that are using ILI data to 
estimate burden of influenza on primary care level, our estimates tend 
to be substantially higher. Paget has estimated the burden of paedi-
atric influenza in four countries (England, the Netherlands, Spain and 
Italy) in the seasons 2002/03–2007/08.14 In the first three countries, 
the estimated season iMAILI attack rate yielded average estimates in 
the range of 0.35%- 2.16% for the age group 0- 4 and 0.32%- 2.96% 
in the age group 5- 14. Only estimates from Italy (8.9% and 9.8%) 
were in a comparable range to ours, but seem to represent an out-
lier among countries that collect ILI data. Population- based studies 
have shown that the actual burden of influenza in children is under- 
recognized with common (ILI) surveillance methods. For example, 
between 2004/05 and 2008/09 Poehling conducted a population- 
based study in three US counties and found that per season, between 
10% and 25% of children aged 0- 4 years sought outpatient medical 
F IGURE  6 Observed and predicted iMAARI attack rate based on iMAARI attack rate in the preceding season. Dots show iMAARI attack 
rates as observed, and lines show modelled iMAARI attack rates as predicted using Poisson regression
Observed Predicted
All
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care because of influenza.15 Our estimates in these two age groups 
between the seasons 2002/03 and 2008/09 ranged from 2% to 
17% (age group 0- 4; median 11%) and from 3% to 13% (age group 
5- 14; median 8%), respectively, and are therefore comparable with 
the thoroughly conducted population- based research study. Similarly, 
in the three seasons following the pandemic, influenza- associated 
consultations by patients with ILI were estimated in a population- 
based surveillance project in 13 US health jurisdictions as 0.7%, 0.2% 
and 1.1%.16 Given that only between 30% and 80% of all influenza 
cases manifest themselves as ILI5-8 and in the same year influenza 
seasons may be quite different in different countries, the estimated 
2.6%, 1.0% and 8.9% in our study lie in a comparable magnitude as 
the US data. We believe that our combination of surveillance (using 
ARI data) followed by modelling estimates the population impact of 
influenza more realistically than sentinel systems that use ILI data. 
Moreover, the surveillance system used provides such estimates not 
just for a few counties for a limited number of seasons, as is the case 
for research studies, but for the entire country, the entire age range 
and every season.
Surveillance systems that collect ILI data may estimate iMAILI by 
multiplying the proportion positive for influenza among ILI patients 
in virological surveillance by the number of ILI patients in the popula-
tion.17 We could not use this approach because syndromic surveillance 
collects data on MAARI, whereas virological surveillance focusses on 
ILI patients. Certainly, the distribution of respiratory viruses among all 
MAARI patients is not the same as for MAILI patients. For example, 
the influenza positivity rate among ARI is considerably lower than for 
ILI. Hence, in our model we do not use the proportion positive for in-
fluenza, but we used the total number of samples that tested positive 
for influenza, and if yes, for which type and subtype. We still have to 
assume that the proportion of iMAILI among iMAARI (or the iMAILI 
to iMAARI ratio) is constant during a given season and does not de-
pend on the influenza type or subtype. The fact that the GAM- excess 
model and the GAM sample- based model estimated a quite similar 
excess in most seasons shows that the course of the laboratory- 
confirmed influenza is suitable as a proxy for the iMAARI attack rate, 
as the GAM- excess model does not imply any assumptions on the 
shape of this course. In fact, we found an almost identical baseline in 
both models. In seasons (07/08, 09/10, 10/11), where we found dif-
ferences in the iMAARI attack rate, these resulted from weeks at the 
beginning or end of the influenza season. Either the observed MAARI 
were below the baseline and hence the GAM sample- based model did 
not follow them (seasons 09/10 and 10/11) or there were additional 
spikes (season 07/08) that were not paralleled in the course of the 
laboratory- confirmed influenza (Fig. S4). As the number of samples 
with laboratory- confirmed influenza was quite low for these periods, 
these deviations in the observed MAARI rate were rather not directly 
connected to influenza.
The previous model10 used sine/cosine curves to calculate pe-
riodicity of the baseline. However, recently the use of splines has 
proved to provide a more flexible tool to estimate irregular periodic 
curves.18 Using 52 knots for the yearly oscillating baseline allowed 
us to construct a quite realistic pattern. A particular characteristic of 
the sin/cos- excess model was that we accounted for oscillations of 
the MAARI baseline with periods of 2 and more years. This allowed 
us to adapt quite well to the MAARI we observed before the period 
of influenza circulation. As described in the Results section, the GAM 
sample- based model does not have this property and we observe 
unusual MAARI activity in the autumn period of several seasons. On 
the other hand, in the sin/cos- excess model we implicitly assumed 
that the (sometimes) unusual autumn MAARI activity continues into 
the period of influenza circulation which is also not always plausi-
ble. In the end, to adequately account for unusual MAARI activity 
in autumn, data about the MAARI or MAILI activity due to other 
pathogens are needed. These are now being collected but compre-
hensively only since 2013/14. Until we are able to construct a stable 
baseline over several years, we will be using a more parsimonious 
model.
Due to the fact that we have estimated the total number of 
iMAARI over a long time frame, we were also able to cumulate these 
over time. While A(H3) has been associated with both very strong and 
quite weak influenza seasons, it has overall led to more than half of all 
iMAARI in those 14 seasons. In contrast, A(H1)prepan has contributed 
the least, first of course because it ceased to circulate after the ad-
vent of A(H1)pdm09, and second because it was generally associated 
with a weaker seasonal impact when it did circulate (Figure 3; Table 1). 
Even both A(H1) variants (pre- pandemic and pdm09) together led only 
to approximately one- quarter of all iMAARI between 2001/02 and 
2014/15.
The age dependency of influenza can be seen nicely also in 
Figures 4 and 5. The two child age groups mostly have a rather high 
attack rate, then it drops and stays rather constant in “younger” adult-
hood (15- 59 years) before it drops again in old age. Several other 
population- based studies or analyses of surveillance data have ob-
served that medically attended respiratory illnesses on primary care 
level decline with age.1,19-22 What this study adds is the additional 
information of the comprehensive burden of all- influenza cases in 
primary care, be they mild or more severe, not only by age, but also 
by type/subtype, over a long time period. It is interesting that the 
“typical” pattern of influenza B shows a substantially higher relative 
iMAARI attack rate among school- age children5-14 compared to that 
in age group 0- 4 (Figure 5, right panel), although in absolute terms 
the attack rate among 5- to 14- year- old children is comparable to that 
caused by A(H3N2). This striking characteristic of influenza B concurs 
with data from two serological studies, one from the Netherlands and 
one from Germany, which investigated the seroprevalence of antibod-
ies against influenza virus types and subtypes by year of age among 
children.23,24 Both studies showed that seroprevalence of antibodies 
against influenza A viruses rises faster in early childhood compared to 
influenza B. In the German study, seroprevalence of antibodies against 
influenza A rises asymptotically with age reaching a rate of approxi-
mately 90% by the age of 6- 7 years. However, seroprevalence rises 
only linearly for influenza B, and at the age of 6- 7 years, 70% of chil-
dren are still lacking detectable IgG antibodies.24
Another interesting outcome of our analysis is that the impact of 
seasons tends to almost oscillate biannually; that is, a strong season 
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is followed by a weaker season (Figure 2). The pandemic only inter-
rupted this pattern for a couple of years. Indeed, when we modelled 
the iMAARI attack rate as an (inverse) function of the magnitude of 
the preceding season, we found a pattern that seems to support this 
observation (Figure 6). However, this is by and large influenced by the 
dynamics of A(H3) and less so by influenza B. The reason for this pat-
tern may be that the degree of population immunity after a heavy sea-
son is large enough to dampen the impact of next season’s influenza 
virus, independently of its type or subtype.
We have to admit the following limitations. First, the weekly 
number of samples taken for virological surveillance is somewhat 
capped because physicians are requested to take no more than three 
to five specimens per week. It is expected that this might overempha-
size a little bit the tail ends of the epidemic, and it requires a season- 
specific factor to calculate iMAARI from the number of confirmed 
influenza viruses. Second, as we are lacking a time series of data on 
RSV (and other respiratory pathogens) and as RSV seasons may over-
lap with influenza epidemics,25 we might overestimate the burden 
of influenza to a certain extent. However, data from the above men-
tioned study in four European countries found that in two of the four 
countries, RSV was not a significant term in the model (explaining 
MAILI), and in two others, the model attributed only 11% and 13%, 
respectively, to RSV.14 We therefore do not believe that we vastly 
overestimate the seasonal attack rate of iMAARI by neglecting RSV 
circulation.
5  | CONCLUSION
We present a GAM model that is capable of estimating the 
influenza- attributable MAARI attack rate on the basis of aggregated 
ARI as well as virological data stemming from a sentinel physician 
network. The model has been capable to yield type- and subtype- as 
well as age- specific estimates of the burden of influenza on primary 
care level. The estimated seasonal iMAARI attack rate is substan-
tially higher than in other countries using ILI surveillance data and 
agrees better with detailed population- based research studies. 
About half of the impact during these 14 seasons was caused by 
A(H3). Regularly the two child age groups (0- 4, 5- 14) had the high-
est iMAARI attack rates reaching frequently levels up to 15%- 20%. 
Influenza B has led to an exceptionally high impact among 5- to 
14- year- old children, compared to all other age groups. The degree 
of influenza activity in 1 year seems to influence the degree in the 
next, largely influenced by the activity of A(H3). The model is ready 
to integrate data from other pathogens that will become available 
in the near future.
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